Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Total Non-Current Liabilities: 2020-2024

  • Whitehawk Therapeutics' Total Non-Current Liabilities was N/A to $17.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $17.6 million, marking a year-over-year change of. This contributed to the annual value of $17.6 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Total Non-Current Liabilities of $17.6 million as of Q4 2024, which was up 7.31% from $16.4 million recorded in Q3 2024.
  • In the past 5 years, Whitehawk Therapeutics' Total Non-Current Liabilities registered a high of $31.2 million during Q4 2020, and its lowest value of $16.4 million during Q3 2024.
  • For the 2-year period, Whitehawk Therapeutics' Total Non-Current Liabilities averaged around $18.0 million, with its median value being $17.6 million (2024).